Nicotine, through its binding to α7-nAChRs, has been shown to prevent and reverse the accumulation of β-amyloid in the brain, highlighting a potential new therapeutic target for preventing the development of post-stroke dementia [96]. Here, CHRNA7 is linked to dementia.